Sarah Faiz

Clermont-ferrand, France

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 16 publications

An atypical and diagnostically challenging case of pediatric metastatic Crohn's disease.

An atypical and diagnostically challenging case of pediatric metastatic Crohn's disease.

Journal: JAAD case reports

Published: April 21, 2026

Durable remission with no survival reduction after mogamulizumab discontinuation in Sézary syndrome.

Durable remission with no survival reduction after mogamulizumab discontinuation in Sézary syndrome.

Journal: The British journal of dermatology

Published: March 13, 2026

Subcutaneous rituximab in indolent primary cutaneous B cell lymphoma: A case series of 5 patients with the evaluation of the medico economic impact.

Subcutaneous rituximab in indolent primary cutaneous B cell lymphoma: A case series of 5 patients with the evaluation of the medico economic impact.

Journal: Therapie

Published: February 25, 2025

Erratum: Real-life efficacy of immunotherapy for Sézary syndrome: a multicenter observational cohort study.

Erratum: Real-life efficacy of immunotherapy for Sézary syndrome: a multicenter observational cohort study.

Journal: EClinicalMedicine

Published: December 25, 2024

Increased risk of cutaneous squamous cell carcinomas in patients with Sézary syndrome: A nationwide multicenter retrospective study.

Increased risk of cutaneous squamous cell carcinomas in patients with Sézary syndrome: A nationwide multicenter retrospective study.

Journal: Journal of the American Academy of Dermatology

Published: July 17, 2024

Mogamulizumab-induced bone granuloma.

Mogamulizumab-induced bone granuloma.

Journal: Joint bone spine

Published: July 14, 2024

Efficacy and tolerance of dupilumab in patients with moderate-to-severe atopic dermatitis and obesity.

Efficacy and tolerance of dupilumab in patients with moderate-to-severe atopic dermatitis and obesity.

Journal: Journal of the European Academy of Dermatology and Venereology : JEADV

Published: April 27, 2024

Real-life efficacy of immunotherapy for Sézary syndrome: a multicenter observational cohort study.

Real-life efficacy of immunotherapy for Sézary syndrome: a multicenter observational cohort study.

Journal: EClinicalMedicine

Published: February 20, 2024

Evolution of patients with Sézary syndrome after mogamulizumab discontinuation for any cause except progression: a multicentre retrospective study (Moga-stop Study).

Evolution of patients with Sézary syndrome after mogamulizumab discontinuation for any cause except progression: a multicentre retrospective study (Moga-stop Study).

Journal: The British journal of dermatology

Published: January 14, 2024

Genomic profiling of mycosis fungoides identifies patients at high risk of disease progression.

Genomic profiling of mycosis fungoides identifies patients at high risk of disease progression.

Journal: Blood advances

Published: December 12, 2023

Real-life use of apremilast for the treatment of psoriasis in patients with oncological comorbidities: a retrospective descriptive multicentre study in France.

Real-life use of apremilast for the treatment of psoriasis in patients with oncological comorbidities: a retrospective descriptive multicentre study in France.

Journal: European journal of dermatology : EJD

Published: May 08, 2023

Photodynamic therapy for the treatment of primary cutaneous B-cell marginal zone lymphoma: A series of 4 patients.

Photodynamic therapy for the treatment of primary cutaneous B-cell marginal zone lymphoma: A series of 4 patients.

Journal: JAAD case reports

Published: March 02, 2023

Showing 1-12 of 16

Last Updated: 09/26/2026